Predialysis nephrology care and its impact on initial vascular access type in hemodialysis patients in Jordan

Abdurrahman M Hamadah1, Kamel Gharaibeh2

  • 1Department of Internal Medicine, Faculty of Medicine, Hashemite University, Zarqa, Jordan.

Insights

Early nephrology referral significantly increases arteriovenous fistula (AVF) use for hemodialysis (HD) in Jordan. Many patients initiating HD lacked prior nephrology care, resulting in central venous catheter (CVC) use.

Area of Science:

  • Nephrology
  • Vascular Access Surgery
  • Public Health Policy

Background:

  • Patients with chronic kidney disease (CKD) progressing to end-stage renal disease (ESRD) require timely nephrology referral for appropriate vascular access planning.
  • Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD) due to its lower complication rates compared to central venous catheters (CVCs).
  • The impact of early nephrology referral on AVF utilization among ESRD patients initiating HD in Jordan remains understudied.

Purpose of the Study:

  • To investigate the rate of early nephrology referral for CKD patients initiating HD in Jordan.
  • To assess the impact of prior nephrology care on the type of vascular access used at the initiation of hemodialysis.
  • To identify opportunities for improving AVF utilization through enhanced nephrology referral pathways.

Main Methods:

  • A cross-sectional study involving patients on in-center HD at a Jordan Ministry of Health dialysis unit.
  • Data collection included patient interviews and medical record reviews to determine prior nephrology care and HD access type.
  • Statistical analysis compared AVF utilization rates between patients with and without documented prior nephrology care.

Main Results:

  • Of 93 eligible patients, only 54% received nephrology care before initiating HD; 48% of those starting with a CVC had prior nephrology care.
  • All patients (100%) who initiated HD with an AVF had received prior nephrology care, compared to none of the patients who initiated with a CVC.
  • Patients seen by nephrology >1 year before HD initiation were significantly more likely to use an AVF (24%) versus those with no prior nephrology care (0%).

Conclusions:

  • A substantial proportion of ESRD patients in Jordan initiate HD without prior nephrology consultation, leading to suboptimal vascular access.
  • Early and adequate nephrology referral is strongly associated with the use of AVF at the initiation of hemodialysis.
  • Implementing national strategies to improve nephrology referral for advanced CKD patients is crucial for increasing AVF utilization and improving patient outcomes.

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
536
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
657
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.5K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
430